OpenAI Rejects Apple Trade Secret Theft Claims 
SEC Seeks ISS Client Voting Records in Proxy Adviser Probe 
Maduro Seeks Dismissal of US Drug Trafficking Charges 
US Judge Dismisses Imran Ahmed Deportation Lawsuit 
Kioxia Rules Out SK Hynix Manufacturing Partnership 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
Judge Rejects Minnesota Bid to Force ICE Agent Extradition 
TSMC August Revenue Jumps 53% on AI Chip Demand 
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children 
Huawei Launches Mate XT2 Foldable Phone in China 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Brazil Court Suspends Sigma Lithium Mine Operations 
Anthropic Drops $6 Billion Decart AI Acquisition Talks 
Google Revamps EU Search Results to Meet DMA Rules 
Apple Unveils $1,999 Foldable iPhone Duo 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Add as a preferred source on Google
The Missouri Supreme Court rejected Johnson & Johnson's appeal of a ruling by the Missouri Court of Appeals awarding $2.12 billion damages to women who blamed the company's asbestos-tainted products for their ovarian cancer.
The New Brunswick, New Jersey-based firm called the verdict a product of fundamentally flawed trial, grounded in a faulty presentation of the facts and vowed to elevate the case to the US Supreme Court.
Johnson & Johnson insists that there were decades of independent scientific evaluations that found their product safe, asbestos-free, and not cancer-causing.
In July 2018, a jury ruled that Johnson & Johnson was liable $4.69 billion to the complainants.
The Missouri Court of Appeals upheld the jury verdict on June 23 but reduced the payout to $2.12 billion after dismissing claims by 22 plaintiffs.
It said that it may be inferred from evidence that the company disregarded consumer safety for profit.
Kevin Parker, a lawyer for the plaintiffs, said that Johnson & Johnson should accept the verdict of the jury and the appellate court and compensate the victims.
Johnson & Johnson said it would set aside a $2.1 billion reserve for the verdict.
The company, which said that it would stop selling its Baby Powder talc in the US and Canada, revealed that it faces over 21,800 lawsuits claiming that its talc products contain asbestos, a known carcinogen.
Johnson & Johnson's baby powder was intensely scrutinized for safety after a 2018 Reuters investigative report said that it knew for decades that about the asbestos contamination of its talc.
Evidence showed that from at least 1971 to the early 2000s,
Johnson & Johnson's raw talc and finished powders have tested positive for small amounts of asbestos.
